1-2 of 2
Nora Rebeka Javorniczky
Close
Sort by
Journal Articles

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease

Clinical Trials & Observations
Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi-Bin Chen, Ryotaro Nakamura, James L. M. Ferrara, John E. Levine
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5189–5198.
https://doi.org/10.1182/bloodadvances.2023009853
Published: 2023
Includes: Supplemental data
Journal Articles

The utility of biomarkers in acute GVHD prognostication

Clinical Trials & Observations
Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J. Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chantiya Chanswangphuwana, Muna Qayed, Sabrina Kraus, Matthias Eder, Nora Rebeka Javorniczky, Stephan A. Grupp, Carrie L. Kitko, Pietro Merli, Paibel Aguayo-Hiraldo, Matthias Wölfl, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Alina Khan, Steven Kowalyk, George Morales, Rachel Young, Ryotaro Nakamura, Yi-Bin Chen, John E. Levine, James L. M. Ferrara
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5152–5155.
https://doi.org/10.1182/bloodadvances.2023009929
Published: 2023
Includes: Supplemental data